JP7246644B2 - 肺炎球菌表面プロテインａの選択されたアルファヘリカルドメインおよびプロリンリッチドメインを組み合わせた肺炎球菌ワクチン - Google Patents

肺炎球菌表面プロテインａの選択されたアルファヘリカルドメインおよびプロリンリッチドメインを組み合わせた肺炎球菌ワクチン Download PDF

Info

Publication number
JP7246644B2
JP7246644B2 JP2019528878A JP2019528878A JP7246644B2 JP 7246644 B2 JP7246644 B2 JP 7246644B2 JP 2019528878 A JP2019528878 A JP 2019528878A JP 2019528878 A JP2019528878 A JP 2019528878A JP 7246644 B2 JP7246644 B2 JP 7246644B2
Authority
JP
Japan
Prior art keywords
seq
ahd
prd
clade
pspa
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2019528878A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020502075A5 (https=
JP2020502075A (ja
Inventor
イー ブライルズ、デイヴィッド
宏 清野
ケネラー、ロバート
ムカージ、レシュミ
ゲンシュマー、クリストファー
義和 幸
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Tokyo NUC
Original Assignee
University of Tokyo NUC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Tokyo NUC filed Critical University of Tokyo NUC
Publication of JP2020502075A publication Critical patent/JP2020502075A/ja
Publication of JP2020502075A5 publication Critical patent/JP2020502075A5/ja
Application granted granted Critical
Publication of JP7246644B2 publication Critical patent/JP7246644B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55583—Polysaccharides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2019528878A 2016-12-03 2017-12-01 肺炎球菌表面プロテインａの選択されたアルファヘリカルドメインおよびプロリンリッチドメインを組み合わせた肺炎球菌ワクチン Active JP7246644B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662429782P 2016-12-03 2016-12-03
US62/429,782 2016-12-03
PCT/US2017/064347 WO2018102774A2 (en) 2016-12-03 2017-12-01 Pneumococcal vaccine combining selected alpha helical domains and proline rich domains of pneumococcal surface protein a

Publications (3)

Publication Number Publication Date
JP2020502075A JP2020502075A (ja) 2020-01-23
JP2020502075A5 JP2020502075A5 (https=) 2021-07-26
JP7246644B2 true JP7246644B2 (ja) 2023-03-28

Family

ID=61028164

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019528878A Active JP7246644B2 (ja) 2016-12-03 2017-12-01 肺炎球菌表面プロテインａの選択されたアルファヘリカルドメインおよびプロリンリッチドメインを組み合わせた肺炎球菌ワクチン

Country Status (7)

Country Link
US (1) US11806392B2 (https=)
EP (1) EP3548076A2 (https=)
JP (1) JP7246644B2 (https=)
KR (1) KR102608642B1 (https=)
CN (1) CN110381992A (https=)
AU (2) AU2017366726B2 (https=)
WO (1) WO2018102774A2 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7246644B2 (ja) 2016-12-03 2023-03-28 ザ ユーエービー リサーチ ファウンデイション 肺炎球菌表面プロテインａの選択されたアルファヘリカルドメインおよびプロリンリッチドメインを組み合わせた肺炎球菌ワクチン
WO2020203731A1 (ja) 2019-03-29 2020-10-08 国立大学法人東京大学 肺炎球菌表層タンパク質
CN110452374B (zh) * 2019-08-30 2021-09-28 苏州大学 具有高效基因递送能力的三维球形α螺旋阳离子聚多肽及其制备方法与应用
WO2023107951A1 (en) 2021-12-08 2023-06-15 Immunitybio, Inc. Neoepitope vaccine delivery vehicle and methods of making the same
KR20260040241A (ko) 2023-07-12 2026-03-24 비로메틱스 아게 폐렴구균 항원의 조성물

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007089866A2 (en) 2006-02-02 2007-08-09 University Of Alabama Research Foundation Non-coiled protective regions of pneumococcal surface proteins pspa and pspc
WO2014045621A1 (ja) 2012-09-19 2014-03-27 国立大学法人大阪大学 肺炎球菌表面タンパク質ａを含む肺炎球菌ワクチン
WO2015089587A1 (en) 2013-12-18 2015-06-25 Commonwealth Scientific And Industrial Research Organisation Lipid comprising long chain polyunsaturated fatty acids
WO2015122518A1 (ja) 2014-02-17 2015-08-20 Ｌｓｉｐファンド運営合同会社 肺炎球菌経鼻ワクチン

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6592876B1 (en) 1993-04-20 2003-07-15 Uab Research Foundation Pneumococcal genes, portions thereof, expression products therefrom, and uses of such genes, portions and products
US5476929A (en) 1991-02-15 1995-12-19 Uab Research Foundation Structural gene of pneumococcal protein
DK0571538T5 (da) 1991-02-15 2002-03-04 Uab Research Foundation Strukturgen for pneumokokprotein
US5980909A (en) 1991-02-15 1999-11-09 Uab Research Foundation Epitopic regions of pneumococcal surface protein A
US5955089A (en) 1993-04-20 1999-09-21 Uab Research Foundation Strain selection of pneumococcal surface proteins
CA2116261A1 (en) 1993-04-20 1994-10-21 David E. Briles Epitopic regions of pneumococcal surface protein a
JP5344558B2 (ja) 2008-10-31 2013-11-20 国立大学法人 東京医科歯科大学 カチオン性ナノゲルを用いる粘膜ワクチン
AU2012347470B2 (en) 2011-12-09 2017-02-02 Medtronic Ireland Manufacturing Unlimited Company Therapeutic neuromodulation of the hepatic system
RU2510281C2 (ru) 2012-06-22 2014-03-27 Общество с ограниченной ответственностью "Эпитоп" (ООО "Эпитоп") ВАКЦИНА ПРОТИВ ПНЕВМОНИИ, ВЫЗЫВАЕМОЙ Streptococcus pneumoniae, НА ОСНОВЕ ГИБРИДНОГО БЕЛКА
US9943583B2 (en) * 2013-12-03 2018-04-17 Universität Zürich Proline-rich peptides protective against S. pneumoniae
CN103834667B (zh) * 2013-12-31 2016-08-17 李越希 化学合成的肺炎链球菌PspA蛋白胞外区基因片段及其表达、应用
CN104888224B (zh) * 2015-03-25 2019-02-01 中山大学 一种两亲性多糖衍生物/泊洛沙姆温敏型原位水凝胶及其制备方法
CN104844712B (zh) * 2015-04-03 2019-06-28 长春百克生物科技股份公司 肺炎链球菌蛋白抗原及其制备方法和应用
JP7246644B2 (ja) 2016-12-03 2023-03-28 ザ ユーエービー リサーチ ファウンデイション 肺炎球菌表面プロテインａの選択されたアルファヘリカルドメインおよびプロリンリッチドメインを組み合わせた肺炎球菌ワクチン

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007089866A2 (en) 2006-02-02 2007-08-09 University Of Alabama Research Foundation Non-coiled protective regions of pneumococcal surface proteins pspa and pspc
WO2014045621A1 (ja) 2012-09-19 2014-03-27 国立大学法人大阪大学 肺炎球菌表面タンパク質ａを含む肺炎球菌ワクチン
WO2015089587A1 (en) 2013-12-18 2015-06-25 Commonwealth Scientific And Industrial Research Organisation Lipid comprising long chain polyunsaturated fatty acids
WO2015122518A1 (ja) 2014-02-17 2015-08-20 Ｌｓｉｐファンド運営合同会社 肺炎球菌経鼻ワクチン

Also Published As

Publication number Publication date
CA3044112A1 (en) 2018-06-07
AU2017366726B2 (en) 2021-12-09
RU2019118969A (ru) 2021-01-11
CN110381992A (zh) 2019-10-25
US11806392B2 (en) 2023-11-07
WO2018102774A2 (en) 2018-06-07
KR20190110090A (ko) 2019-09-27
WO2018102774A3 (en) 2018-07-12
WO2018102774A8 (en) 2019-05-31
EP3548076A2 (en) 2019-10-09
KR102608642B1 (ko) 2023-11-30
AU2021269320A1 (en) 2021-12-09
RU2019118969A3 (https=) 2021-01-11
US20190351043A1 (en) 2019-11-21
AU2017366726A1 (en) 2019-05-30
JP2020502075A (ja) 2020-01-23

Similar Documents

Publication Publication Date Title
JP7246644B2 (ja) 肺炎球菌表面プロテインａの選択されたアルファヘリカルドメインおよびプロリンリッチドメインを組み合わせた肺炎球菌ワクチン
EP2931896B1 (en) Modified coiled coil type proteins having improved properties
JP6195089B2 (ja) ストレプトコッカス・ニューモニエによる肺炎に対するキメラタンパク質ワクチン
WO2020220846A1 (zh) 一种可自组装为蛋白纳米颗粒的融合蛋白及其应用
JP6434017B2 (ja) マイコプラズマ属菌種の感染を予防する組成物
JP2005523000A (ja) 多価連鎖球菌性ワクチン組成物および使用方法
CN107737334B (zh) 一种预防a型链球菌感染的广谱多联亚单位疫苗
JP2001515723A (ja) Ａ群連鎖球菌ワクチン
Shivachandra et al. Immunogenicity of recombinant Omp16 protein of Pasteurella multocida B: 2 in mouse model
AU761394B2 (en) Superoxide dismutase as a vaccine antigen
JP4749641B2 (ja) ワクチン用の肺炎球菌タンパク質の相同体および断片
CA3044112C (en) Pneumococcal vaccine combining selected alpha helical domains and proline rich domains of pneumococcal surface protein a
RU2794625C2 (ru) Пневмококковая вакцина, сочетающая выбранные альфа-спиральные домены и богатые пролином домены пневмококкового поверхностного белка а
AU2002216863B8 (en) Streptococcus pyogenes antigens and corresponding DNA fragments
KR20200046059A (ko) 그룹 a 스트렙토코쿠스에 대한 면역원성 펩티드
KR20230163500A (ko) 면역원성 융합 단백질
CN102516373B (zh) 去除人同源性的肺炎链球菌表面蛋白a、纯化方法及用途
CA2961883A1 (en) Combined enterotoxigenic escherichia coli and campylobacter jejuni recombinant construct
CN121490069A (zh) 肺炎链球菌蛋白疫苗
AU2007202175B2 (en) Group B Streptococcus Antigens
HK1208632B (en) Chimeric protein vaccine against pneumonia caused by streptococcus pneumoniae

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20201119

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20201119

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210526

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20211101

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220127

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20220621

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20220919

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20221118

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20221118

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20230220

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20230307

R150 Certificate of patent or registration of utility model

Ref document number: 7246644

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250